Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
Integrating Transparent Models, LLMs, and Practitioner-in-the-Loop: A Case of Nonprofit Program Evaluation
arXiv:2510.19799v1 Announce Type: cross Abstract: Public and nonprofit organizations often hesitate to adopt AI tools because most models are opaque even though standard approaches typically analyze aggregate patterns rather than offering actionable, case-level guidance. This study tests a practitioner-in-the-loop workflow that pairs transparent decision-tree models with large language models (LLMs) to improve predictive accuracy, interpretability, and the generation of practical insights. Usin
-
Omics in Gastric
-
Beyond Biomarkers: Machine Learning-Driven Multiomics for Personalized Medicine in Gastric Cancer
J Pers Med. 2025 Apr 24;15(5):166. doi: 10.3390/jpm15050166.ABSTRACTGastric cancer (GC) remains one of the leading causes of cancer-related mortality worldwide, with most cases diagnosed at advanced stages. Traditional biomarkers provide only partial insights into GC's heterogeneity. Recent advances in machine learning (ML)-driven multiomics technologies, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, pathomics, and radiomics, have facilitated a deeper understanding
Beyond Biomarkers: Machine Learning-Driven Multiomics for Personalized Medicine in Gastric Cancer
J Pers Med. 2025 Apr 24;15(5):166. doi: 10.3390/jpm15050166.
ABSTRACT
Gastric cancer (GC) remains one of the leading causes of cancer-related mortality worldwide, with most cases diagnosed at advanced stages. Traditional biomarkers provide only partial insights into GC's heterogeneity. Recent advances in machine learning (ML)-driven multiomics technologies, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, pathomics, and radiomics, have facilitated a deeper understanding of GC by integrating molecular and imaging data. In this review, we summarize the current landscape of ML-based multiomics integration for GC, highlighting its role in precision diagnosis, prognosis prediction, and biomarker discovery for achieving personalized medicine.
PMID:40423038 | PMC:PMC12113022 | DOI:10.3390/jpm15050166
-
Oncogene - Issue - nature.com science feeds
-
Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway
Oncogene, Published online: 18 May 2023; doi:10.1038/s41388-023-02716-4Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway
Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway
Oncogene, Published online: 18 May 2023; doi:10.1038/s41388-023-02716-4
Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway